What is it about?
Autoimmune hemolytic anemia (AIHA) is a pathological process involving the destruction of red blood cells by the humoral immune system. Although there is a well-established relationship between the presence of AIHA and lymphoproliferative malignancies, AIHA rarely presents in association with solid malignancies.
Featured Image
Photo by Anirudh on Unsplash
Why is it important?
Few cases of solid cancer associated with AIHA have been reported. AIHA rarely presents as a paraneoplastic syndrome indicative of solid cancer. We report a case of breast cancer revealed by AIHA.
Perspectives
The paraneoplastic manifestation of hemolytic anemia in patients with solid tumors is often a sign of poor prognosis. In rare cases, it is a feature of an occult primary malignant neoplasm. Hemolysis usually occurs late in the course of the disease and manifests abruptly as severe anemia. We report a case of hemolytic anemia in breast carcinoma.
Acquire Publications
Read the Original
This page is a summary of: Breast Cancer and Autoimmune Hemolytic Anemia: A Rare Paraneoplastic Syndrome, Journal of Case Reports and Medical History, December 2023, Acquire Publications LLC,
DOI: 10.54289/jcrmh2300142.
You can read the full text:
Contributors
The following have contributed to this page
